Navigation Links
Ovarian cancer advances when genes are silenced
Date:12/13/2010

DURHAM, N.C. There are many mechanisms that alter the activity of genes direct changes to the DNA code like mutations and deletions, or changes that control when genes are switched on and off, called epigenetic means. Tumor-suppressor genes are often inactivated through epigenetics, which provides an opening for the cancerous growth of cells.

Researchers at the Duke Cancer Institute have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced by DNA methylation a mechanism for turning off genes -- in tumor cells.

The researchers performed a series of studies on cancer cell lines and primary tumor specimens from ovarian cancer patients by comparing the genome-wide gene expression profiles of cells that were treated or mock-treated with drugs that inhibit DNA methylation. From these studies they identified 378 candidate methylated genes. From this group, all 43 of the predicted genes the researchers analyzed showed methylation in ovarian cancers.

"We were very surprised to see that so many of these genes were part of one pathway, the TGF-beta signaling pathway, so we conducted studies to further explore how methylation might have an effect on the pathway," said senior author Susan Murphy, Ph.D., assistant professor in the Division of Gynecologic Oncology in Duke OB-GYN and in the Department of Pathology.

When the researchers treated tumor cells with methylation inhibitors, the TGF-beta pathway showed increased activity. This is an important signaling pathway that directs many processes in cells. A smoothly functioning TGF-beta pathway ensures proper cell growth, cell differentiation, and apoptosis (programmed cell death), and helps prevent tumor formation. When this pathway is deregulated, it can instead help tumors grow and metastasize.

The study showed for the first time that TGF-beta pathway function is regulated through methylation. "This is only one piece of a larger puzzle about the biology of ovarian cancer, but we can say that DNA methylation does have an influence on suppressing TGF-beta pathway signaling, which contributes to ovarian cancer."

In addition, the genes they studied included a cluster of genes that strongly correlated with TGF-beta pathway activity in specimens from older women, which suggested that age-related epigenetic changes can accumulate and may contribute to cancer.

Murphy said two different groups of patients the team identified might need different approaches.

"Some women with ovarian cancer have lower expression of these tumor-suppressing genes and may be amenable to epigenetic therapies that lead to gene reactivation with the caveat that at this point we can't epigenetically reactivate just one gene or a specific group of genes," Murphy said. "Another group of women with ovarian cancer have higher expression of these genes, suggesting it may be possible to specifically inhibit particular components in this pathway to stop tumor development or progression."


'/>"/>

Contact: Mary Jane Gore
mary.gore@duke.edu
919-660-1309
Duke University Medical Center
Source:Eurekalert

Related medicine news :

1. How to make the best decisions when at high risk for breast or ovarian cancer
2. Foster Friess commits up to $50,000 to help TGen fight ovarian cancer
3. Study finds delay in referrals for older women with ovarian cancer
4. Pre-Diagnosis Diet Linked to Ovarian Cancer Survival
5. Only women with Western Swedish breast cancer gene run higher risk of ovarian cancer
6. Ovarian cancer study offers vital clues for new therapies
7. Researchers identify a new breast and ovarian cancer susceptibility gene
8. Study Makes Strides in Understanding Ovarian Cancer
9. PMH cancer researchers link ovarian hormone to breast stem cells growth
10. CA-125 change over time shows promise as screening tool for early detection of ovarian cancer
11. Early Detection of Ovarian Cancer Moves Closer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , ... February 22, 2017 , ... ... approach, leads to fewer trips the emergency room, fewer hospital admissions, and better ... Journal of Managed Care® (AJMC®) finds. The study can be found here ...
(Date:2/22/2017)... ... February 22, 2017 , ... Sideline Products participated in the World ... TV host Tom Seay and his production crew. Tom Seay’s program “Best of ... the world. Saddle Sidekicks will be featured on April 6, 2017. After the ...
(Date:2/22/2017)... Charleston, WV (PRWEB) , ... February 22, 2017 ... ... has awarded a contract to Quality Insights to help small practices in Delaware, ... Quality Payment Program, established by the Medicare Access and CHIP Reauthorization Act of ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... percent of those report that family members or friends have also commented about ... from hearing loss wear hearing aids. One reason, suggested by 89 percent of ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... military veterans who suffer from combat-related PTSD. , Established in 1977, our organization ... Vietnam-era, the challenges of military returning to civilian life were evident and served ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... Research and Markets has announced the addition of the ... Trend Indicator):Analysis By Region, By Country (2016-21)" report to their ... Global ... CAGR of 5.33% during 2016-2021 The strong growth is ... demand of digital thermometer. Apart from that, the downfall in the ...
(Date:2/22/2017)... 22, 2017  Allergan plc (NYSE: AGN), a ... a Gold sponsor of the Alzheimer,s Foundation of ... This tour commemorates AFA,s15 years of educating individuals ... programs. The tour will include AFA,s free Concepts ... displays of the AFA Quilt to Remember. ...
(Date:2/22/2017)... February 22, 2017 According to a new market ... In-Line, At-Line), Products and Services (Analyzers, Probes & Sensors), End - User ... MarketsandMarkets, the global market is poised to reach USD 3.30 Billion by ... from 2016 to 2021. Continue Reading ... ...
Breaking Medicine Technology: